Barclays keeps an Overweight rating on UnitedHealth (UNH) with a $352 price target after the company announced that a preliminary review of 2026 star ratings data shows 78% of its Medicare Advantage membership will be in a 4-star or higher plan, which is consistent with its 76% bonus membership in 2025 star ratings. The stock in premarket trading is up 4% to $320.25. The new ratings impact the 2027 payment year, and should help alleviate investor concerns, the analyst tells investors in a research note. The firm sees the news as solidifying UnitedHealth’s investment thesis around multi-year margin improvement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth expects most MA members in 4 star or higher plans, shares up 4.5%
- Sight Sciences OMNI Surgical System to be included in UnitedHealthcare coverage
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
- UNH vs. CVS: Which Healthcare Stock Has More Upside, According to Wall Street?
- EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz